Effect of
Fucoxanthin and Xanthigen[TM], A phytomedicine containing
fucoxanthin and pomegranate seed oil, on energy expenditure in obese non-diabetic female volunteers: a double-blind, randomized and placebo-controlled trial.
The effect of Xanthigen[TM], a phytomedicine containing
fucoxanthin and pomegranate seed oil, on body weight in obese non-diabetic female volunteers: a double-blind, randomized and placebo- controlled trial.
Tissue Pigment Origin Wild Hepatopancreas Astaxanthin F 22.82 [+ or -] 4.19 a Astaxanthin E 144.1 [+ or -] 13.9 b
Fucoxanthin nd Zeaxanthin 2.96 [+ or -] 0.46 a Canthaxanthin 3.23 [+ or -] 0.45 [beta]-carotene 12.2 [+ or -] 1.20 a Exoskeleton Astaxanthin F 1.51 [+ or -] 0.11 Astaxanthin E 0.74 [+ or -] 0.49 b Zeaxanthin 0.06 [+ or -] 0.01 Canthaxanthin 0.04 [+ or -] 0.01 [beta]-carotene 0.55 [+ or -] 0.08 b Muscle Astaxanthin F 0.73 [+ or -] 0.04 Astaxanthin E 0.63 [+ or -] 0.07 b Zeaxanthin 0.03 [+ or -] 0.01 Canthaxanthin 0.02 [+ or -] 0.01 [beta]-carotene 0.09 [+ or -] 0.04 Tissue Origin Reared Ext.
Fucoxanthin showed cytotoxic effects by inducing apoptosis of prostate cancer cell line PC-3 (Kotake-Nara et al, 2001), leukemia HL-6 (Nakazawa et al., 2009), and 6 colorectal cell lines, Caco-2, WiDr, HCT116, DLD-1, SW620, Colo205, Caco-2 cell lines (Takahashi et al., 2015).
Nutraceutical effects of
fucoxanthin for obesity and diabetes therapy: a review.
Peridinin (PER),
fucoxanthin (FUC) and zeaxanthin (ZEA) have been commonly used to designate dinoflagellates, diatoms and cyanobacteria, respectively (Jeffrey et al., 1997).
Zahedi, "Seasonal variation of total lipid, fatty acids,
fucoxanthin content, and antioxidant properties of two tropical brown algae (Nizamuddinia zanardinii and Cystoseira indica) from Iran," Journal of Applied Phycology, vol.
Miyashita, "The carotenoid
fucoxanthin from brown seaweed affects obesity," Lipid Technology, vol.